Genetic variants of heat shock protein A1L2437 and A1B1267 as possible risk factors for hepatocellular carcinoma in India

Journal of Viral Hepatitis

Volumn 20, Issue 4, 2013, Pages

  Medhi, S ^a   Sarma, M P ^a   Asim, M ^a   Kar, P ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

heat shock protein 70; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma

Indexed keywords

AFLATOXIN; GENOMIC DNA; HEAT SHOCK PROTEIN;

ADULT; ARTICLE; CANCER RISK; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HOMOZYGOSITY; HUMAN; INDIA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; URINE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84875212506     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12021     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Estimating the world cancer burden:Globocan 2000. Int J Cancer 2001; 94 (2): 153-156.
2. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
3. Pisani P,. Burden of cancer in developing countries. IARC Sci Publ 1994; 129: 31-39.
4. Chen C, Chen PJ, Yang PM, et al,. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol 1997; 92 (12): 2257-2259.
5. Bruix J, Sherman M, Llovet JM, et al,. EASL Panel of Experts on HCC.Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35 (3): 421-430.
6. Yoshizawa H,. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002; 62 (suppl 1): 8-17.
7. Kumar M, Kumar R, Hissar SS, et al,. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007; 22: 1104-1111.
8. El-Serag HB, Rudolph KL,. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132 (7): 2557-2576.
9. Laurent-Puig P, Zucman-Rossi J,. Genetics of hepatocellular tumors. Oncogene 2006; 25: 3778-3786.
10. Yu MW, Chang HC, Liaw YF, et al,. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000; 92 (14): 1159-1164.
11. Yu MW, Chang HC, Chen PJ, et al,. Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan. Int J Epidemiol 2002; 31: 1008-1015.
12. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N,. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 2007; 14 (12): 841-848.
13. Ciocca DR, Calderwood SK,. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005; 10: 86-103.
14. Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J, Jaattela M,. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 2005; 19: 570-582.
15. Baler R, Zou J, Voellmy R,. Evidence for a role of Hsp70 in the regulation of the heat shock response in mammalian cells. Cell Stress Chaperones 1996; 1: 33-39.
16. Asea A, Kraeft SK, Kurt-Jones EA, et al,. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000; 6: 435-442.
17. DeNagel DC, Pierce SK,. A case for chaperones in antigen processing. Immunol Today 1992; 13: 86-89.
18. Milner CM, Campbell RD,. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 1992; 32: 242-251.
19. Milner CM, Campbell RD,. Polymorphic analysis of the three MHC-linked HSP70 genes. Immunogenetics 1992; 36: 357-362.
20. Bruix J, Sherman M, Llovet JM, et al,. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona- 2000 EASL conference. J Hepatol 2001; 35: 421-430.
21. Sambrook, J, Fritsch, EF, Maniatis, T., Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press, 1990: 73.
22. Chouchane L, Ahmed SB, Baccouche S, Remadi S,. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 1997; 80: 1489-1496.
23. Lu SJ, Day NE, Degos L, et al,. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990; 346 (6283): 470-471.
24. Ooi EE, Ren EC, Chan SH,. Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int J Cancer 1997; 74 (2): 229-232.
25. Fattovich G, Stroffoloni T, Zagni I, et al,. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127: S35-S50.
26. Ferlay J, Bray F, Pisani P, parkin DM,. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. Lyon: IARC press, 2001.
27. Stroffolini T, Andreone P, Andriulli A, et al,. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998; 29 (6): 944-952.
28. Asim M, Khan LA, Husain SA, et al,. Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinoma. Dis Markers 2010; 28 (6): 369-376.
29. Asim M, Malik A, Sarma MP, et al,. Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India. J Med Virol 2010; 82 (7): 1115-1125.
30. Kumada T, Toyoda H, Kiriyama S, et al,. Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels. J Hepatol 2009; 50 (4): 729-735.
31. Rino Y, Tarao K, Morinaga S, et al,. Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis. Anticancer Res 2006; 26 (3B): 2221-2226.
32. Murugavel KG, Naranatt PP, Shankar EM, et al,. Prevalence of aflatoxinB1 in liver biopsies of proven hepatocellular carcinoma in India determined by an in-house immunoperoxidase test. J Med Microbiol 2007; 56: 1455-1459.
33. Jeng JE, Tsai JF, Chuang LY, et al,. Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study. Medicine (Baltimore) 2008; 87 (2): 87-98.
34. Pociot F, Ronningen KS, Nerup J,. Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70-2) and HSP70. Hom genes in insulin dependent diabetes mellitus (IDDM). Scand J Immunol 1993; 38: 491-495.
35. Gombos T, Förhécz Z, Pozsonyi Z, Jánoskuti L, Prohászka Z,. Interaction of serum 70-kDa heat shock protein levels and HspA1B (+1267) gene polymorphism with disease severity in patients with chronic heart failure. Cell Stress Chaperones 2008; 13 (2): 199-206.
36. Joo M, Chi JG, Lee H,. Expressions of HSP70 and HSP27 in hepatocellular carcinoma. J Korean Med Sci 2005; 20 (5): 829-834.